State-of-the-Art Review: Demyelinating Diseases in Indonesia

Demyelinating diseases are more common in Indonesia than previously believed. However, it is still a challenge for a country such as Indonesia to implement the scientific medical advances, especially in the diagnostic process of demyelinating diseases, to achieve the best possible outcome for these...

Full description

Bibliographic Details
Main Authors: Hana Larassati, Riwanti Estiasari, Reyhan E. Yunus, Paul M. Parizel
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Multiple Sclerosis International
Online Access:http://dx.doi.org/10.1155/2021/1278503
id doaj-8df19e6402674a8ba1e171f373e1f48f
record_format Article
spelling doaj-8df19e6402674a8ba1e171f373e1f48f2021-07-19T01:05:00ZengHindawi LimitedMultiple Sclerosis International2090-26622021-01-01202110.1155/2021/1278503State-of-the-Art Review: Demyelinating Diseases in IndonesiaHana Larassati0Riwanti Estiasari1Reyhan E. Yunus2Paul M. Parizel3Radiology DepartmentFaculty of Medicine Universitas IndonesiaRadiology DepartmentDavid Hartley Chair of RadiologyDemyelinating diseases are more common in Indonesia than previously believed. However, it is still a challenge for a country such as Indonesia to implement the scientific medical advances, especially in the diagnostic process of demyelinating diseases, to achieve the best possible outcome for these groups of patients, within the constraints of what is socially, technologically, economically, and logistically achievable. In this review, we address the 4 major classes of demyelinating disease: multiple sclerosis (MS), neuromyelitis optica (NMO), anti-MOG-associated encephalomyelitis (MOG-EM), and acute disseminated encephalomyelitis (ADEM), and discuss their prevalence, demographics, clinical diagnosis workup, and imaging features in the Indonesian population, as well as the challenges we face in their diagnosis and therapeutic approach. We hope that this overview will lead to a better awareness of the spectrum of demyelinating diseases of the central nervous system in Indonesia.http://dx.doi.org/10.1155/2021/1278503
collection DOAJ
language English
format Article
sources DOAJ
author Hana Larassati
Riwanti Estiasari
Reyhan E. Yunus
Paul M. Parizel
spellingShingle Hana Larassati
Riwanti Estiasari
Reyhan E. Yunus
Paul M. Parizel
State-of-the-Art Review: Demyelinating Diseases in Indonesia
Multiple Sclerosis International
author_facet Hana Larassati
Riwanti Estiasari
Reyhan E. Yunus
Paul M. Parizel
author_sort Hana Larassati
title State-of-the-Art Review: Demyelinating Diseases in Indonesia
title_short State-of-the-Art Review: Demyelinating Diseases in Indonesia
title_full State-of-the-Art Review: Demyelinating Diseases in Indonesia
title_fullStr State-of-the-Art Review: Demyelinating Diseases in Indonesia
title_full_unstemmed State-of-the-Art Review: Demyelinating Diseases in Indonesia
title_sort state-of-the-art review: demyelinating diseases in indonesia
publisher Hindawi Limited
series Multiple Sclerosis International
issn 2090-2662
publishDate 2021-01-01
description Demyelinating diseases are more common in Indonesia than previously believed. However, it is still a challenge for a country such as Indonesia to implement the scientific medical advances, especially in the diagnostic process of demyelinating diseases, to achieve the best possible outcome for these groups of patients, within the constraints of what is socially, technologically, economically, and logistically achievable. In this review, we address the 4 major classes of demyelinating disease: multiple sclerosis (MS), neuromyelitis optica (NMO), anti-MOG-associated encephalomyelitis (MOG-EM), and acute disseminated encephalomyelitis (ADEM), and discuss their prevalence, demographics, clinical diagnosis workup, and imaging features in the Indonesian population, as well as the challenges we face in their diagnosis and therapeutic approach. We hope that this overview will lead to a better awareness of the spectrum of demyelinating diseases of the central nervous system in Indonesia.
url http://dx.doi.org/10.1155/2021/1278503
work_keys_str_mv AT hanalarassati stateoftheartreviewdemyelinatingdiseasesinindonesia
AT riwantiestiasari stateoftheartreviewdemyelinatingdiseasesinindonesia
AT reyhaneyunus stateoftheartreviewdemyelinatingdiseasesinindonesia
AT paulmparizel stateoftheartreviewdemyelinatingdiseasesinindonesia
_version_ 1721295454191222784